Genmab A/S (GMAB) Reports Q2 New DARZALEX Sales of $2.88B

Go back to Genmab A/S (GMAB) Reports Q2 New DARZALEX Sales of $2.88B
(NASDAQ: GMAB) Delayed: 33.80 -0.61 (1.77%)
Previous Close $34.41    52 Week High
Open $33.96    52 Week Low
Day High $34.19    P/E N/A 
Day Low $33.73    EPS
Volume 336,152